Narcolepsy and other disorders of excessive sleepiness

Medical Clinics of North America

Volumn 88, Issue 3, 2004, Pages 597-610

  Wise, Merrill S ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBUTYRIC ACID; CLOMIPRAMINE; DEXAMPHETAMINE; FLUOXETINE; IMIPRAMINE; METHYLPHENIDATE; MODAFINIL; PEMOLINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AMNESIA; ANAMNESIS; BEHAVIOR THERAPY; CATAPLEXY; CLINICAL FEATURE; HEALTH EDUCATION; HUMAN; HYPERSOMNIA; HYPNAGOGIC HALLUCINATION; MONITORING; NARCOLEPSY; PARASOMNIA; PATIENT EDUCATION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; REVIEW; SLEEP; SLEEP DISORDER; SOMNOLENCE;

DISORDERS OF EXCESSIVE SOMNOLENCE; HLA ANTIGENS; HUMANS; NARCOLEPSY; POLYSOMNOGRAPHY; PSYCHOLOGY; RECURRENCE; SLEEP, REM;

EID: 1842850866     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2004.02.001     Document Type: Review

References (56)

1. American Sleep Disorders Association. International classification of sleep disorders, revised: diagnostic and coding manual. 1997;American Sleep Disorders Association, Rochester, MN.
2. Kryger M.H., Walld R., Manfreda J. Diagnoses received by narcolepsy patients in the year prior to diagnosis by a sleep specialist. Sleep. 25:2002;36-41.
3. Scammell T.E. The neurobiology, diagnosis, and treatment of narcolepsy. Ann Neurol. 53:2003;154-166.
4. Yoss R.E., Daly D. Criteria for the diagnosis of the narcoleptic syndrome. Proc Staff Meet Mayo Clin. 32:1957;320-328.
5. Aldrich M.S. Narcolepsy. Neurology. 42:(Suppl 6):1992;34-43.
6. Young D., Zorick F., Wittig R., Roehrs T., Roth T. Narcolepsy in a pediatric population. Am J Dis Child. 142:1988;210-213.
7. Kotagal S., Hartse K.M., Walsh J.K. Characteristics of narcolepsy in preteenaged children. Pediatrics. 85:1990;205-209.
8. Challamel M.J., Mazzola M.E., Nevsimalova S., Cannard C., Louis J., Revol M. Narcolepsy in children. Sleep. 17:1994;S17-S20.
9. Wise M.S. Childhood narcolepsy. Neurology. 50:(Suppl 1):1998;S37-S42.
10. Guilleminault C., Pelayo R. Narcolepsy in prepubertal children. Ann Neurol. 43:1998;135-142.
11. Han F., Chen E., Wei H., Dong X., He Q., Ding D., et al. Childhood narcolepsy in North China. Sleep. 24:2001;321-324.
12. Yoss R.E., Daly D.D. Narcolepsy in children. Pediatrics. 25:1960;1025-1033.
13. Navelet Y., Anders T., Guilleminault C. Narcolepsy in children. Guilleminault C., Dement W., Passouant P. Narcolepsy. 1976;171-177 Spectrum, New York.
14. Broughton R., Ghanem Q., Hishikawa Y., Sugita Y., Nevsimalova S., Roth B. Life effects of narcolepsy in 180 subjects from North America, Asia, and Europe compared to matched controls. Can J Neurol Sci. 8:1981;199-204.
15. Kales A., Soldatos S.R., Bixler E.O., Caldwell A., Cadieux R.J., Verrechio M., et al. Narcolepsy-cataplexy II. Psychosocial consequences and associated psychopathology. Arch Neurol. 39:1982;169-171.
16. Goswami M. Position paper on the Socioeconomic Aspects of Narcolepsy. 1990;Department of Neurology, Montefiore Medical Center and Albert Einstein College of Medicine.
17. Broughton R.J., Guberman A., Roberts J. Comparison of the psychosocial effects of epilepsy and narcolepsy/cataplexy: a controlled study. Epilepsia. 25:1984;423-433.
18. Aldrich M.S. Diagnostic aspects of narcolepsy. Neurology. 50:(Suppl 1):1998;S2-S7.
19. Vossler D.G., Wyler A.R., Wilkus R.J., Gardner-Walker G., Vlcek B.W. Cataplexy and monoamine oxidase deficiency in Norrie disease. Neurology. 46:1996;1258-1261.
20. Stahl S.M., Layzer R.B., Aminoff M.J., Townsend J.J., Feldon S. Continuous cataplexy in a patient with a midbrain tumor: the limp man syndrome. Neurology. 30:1980;1115-1118.
21. Hartse K.M., Zorick F.J., Sicklesteel J.M., Roth T. Isolated cataplexy: a familial study. Henry Ford Hosp Med J. 36:1988;24-27.
22. Goswami M. The influence of clinical symptoms on quality of life in patients with narcolepsy. Neurology. 50:(Suppl 1):1998;S31-S36.
23. Goswami M., Pollak C.P., Cohen F.L., Thorpy J.M., Kavey N.B., Kutscher A.H. Psychosocial aspects of narcolepsy. 1992;Haworth Press, New York.
24. Kales A., Soldatos C.R., Bixler E.O., Caldwell A., Cadieux R.J., Verrechio J.M., et al. Narcolepsy-Cataplexy: II. Psychosocial consequences and associated psychopathology. Arch Neurol. 39:1982;169-171.
25. Malik S., Boeve B.F., Krahn L.E., Silber M.H. Narcolepsy associated with other central nervous system disorders. Neurology. 57:2001;539-541.
26. Scammell T.E., Nishino S., Mignot E., Saper C.B. Narcolepsy and low CSF orexin (hypocretin) concentration after a diencephalic stroke. Neurology. 56:2001;1751-1753.
27. Clavelou P., Tournilhac M., Vidal C., et al. Narcolepsy associated with arteriovenous malformation of the diencephalon. Sleep. 18:1995;202-205.
28. Manni R., Politini L., Nobili L., Ferrillo F., Livieri C., Veneselli E., et al. Hypersomnia in the Prader Willi syndrome: clinical-electrophysiological features and underlying factors. Clin Neurophysiol. 112:2001;800-805.
29. Martinez-Rodriguez J.E., Lin L., Iranzo A., Genis D., Marti M.J., Santamar J., et al. Decreased hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness. Sleep. 26:2003;287-290.
30. Chesson A.L., Ferber R.A., Fry J.M., Grigg-Damberger M., Hartse K.M., Hurwitz T.D., et al. Practice parameters for the indications for polysomnography and related procedures: an American Sleep Disorders Association Report. Sleep. 20:1997;423-487.
31. Carskadon M.A., Dement W.C., Mitler M.M., Roth T., Westbrook P.R., Keenan S. Guidelines for the Multiple Sleep Latency Test (MSLT): a standardized measure of sleepiness. Sleep. 9:1986;519-524.
32. Thorpy M.J., Westbrook P., Ferber R., Fredrickson P., Mahowald M., Perez-Guerra F., et al. The clinical use of the Multiple Sleep Latency Test: an American Sleep Disorders Association Report. Sleep. 15:1992;268-276.
33. Aldrich M.S., Chervin R.D., Malow B.A. Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy. Sleep. 20:1997;620-629.
34. Mignot E., Chen W., Black J. On the value of measuring CSF hypocretin-1 in diagnosing narcolepsy. Sleep. 26:2003;646-649.
35. Guilleminault C., Mignot E., Grumet F.C. Familial patterns of narcolepsy. Lancet. 2:1989;1376-1379.
36. Mignot E. Genetic and familial aspects of narcolepsy. Neurology. 50:1998;S16-S22.
37. Silber M.H., Krahn L.E., Olson E.J., et al. The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. Sleep. 25:2002;197-202.
38. Hublin C., Kaprio J., Partinen M., et al. The prevalence of narcolepsy: an epidemiological study of the Finnish Twin Cohort. Ann Neurol. 35:1994;709-716.
39. Honda Y., Asaka A., Tanimura M., Furusho T. A genetic study of narcolepsy and excessive daytime sleepiness in 308 families with a narcolepsy or hypersomnia proband. Guilleminault C., Lugaresi E. Sleep/wake disorders: natural history, epidemiology, and long-term evolution. 1983;187-199 Raven Press, New York.
40. Neely S., Rosenberg R., Spire J.P., Antel J., Arnason B.G. HLA antigens in narcolepsy. Neurology. 37:1987;1858-1860.
41. Rogers A.E., Meehan J., Guilleminault C., et al. HLA DR15 (DR2) and DQB1*0602 typing studies in 188 narcoleptic patients with cataplexy. Neurology. 48:1997;1550-1556.
42. Mignot E., Lin L., Rogers W., Honda Y., Qiu X., Lin X., et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet. 68:2001;686-699.
43. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 92:1998;573-585.
44. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P., Danielson P.E., et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A. 95:1998;322-327.
45. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci. 18:1998;9996-10015.
46. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 98:1999;437-451.
47. Marcus J.N., Aschkenasi C.J., Lee C.E., Chemelli R.M., Saper C.B., Yanagisawa M., et al. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol. 435:2001;6-25.
48. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X., et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell. 98:1999;365-376.
49. Peyron C., Faraco J., Rogers W., Ripley B., Overseem S., Charnay Y., et al. A mutation in a case of early onset narcolepsy and generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med. 6:2000;991-997.
50. Bassetti C., Aldrich M.S. Idiopathic hypersomnia: a series of 42 patients. Brain. 120:1997;1423-1435.
51. Critchley M., Hoffman H.L. The syndrome of periodic somnolence and morbid hunger (Kleine-Levin syndrome). BMJ. 1:1942;137-139.
52. Guilleminault C., Faull K.F., Miles L., van den Hoed J. Posttraumatic excessive daytime sleepiness: a review of 20 patients. Neurology. 33:1983;1584-1589.
53. Guilleminault C., Yuen K.M., Gulevich M.G., Karadeniz D., Leger D., Phillip P. Hypersomnia after head-neck trauma: a medicolegal dilemma. Neurology. 54:2000;653-659.
54. Mitler M.M., Aldrich M.S., Koob G.F., Zarcone V.P. Narcolepsy and its treatment with stimulants. Sleep. 17:1994;352-371.
55. Littner M., Johnson S.F., McCall V., Anderson W.M., Davila D., Hartse K., et al. Practice parameters for the treatment of narcolepsy: an update for 2000. Sleep. 24:2001;451-466.
56. Lammers G.J., Arends J., Declerck A.C., Ferrari M.D., Schouwink G., Troos J. Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study. Sleep. 16:1993;216-220.